Is Myriad Genetics, Inc. (NASDAQ:MYGN) Going to Burn These Hedge Funds?

Myriad Genetics, Inc. (NASDAQ:MYGN) shareholders have witnessed an increase in hedge fund sentiment of late.

To the average investor, there are a multitude of methods investors can use to analyze stocks. A couple of the most under-the-radar are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the elite fund managers can outclass their index-focused peers by a significant margin (see just how much).

Just as beneficial, positive insider trading activity is another way to break down the stock market universe. Obviously, there are lots of incentives for an executive to sell shares of his or her company, but just one, very simple reason why they would buy. Plenty of academic studies have demonstrated the valuable potential of this tactic if investors understand what to do (learn more here).

With all of this in mind, it’s important to take a gander at the key action surrounding Myriad Genetics, Inc. (NASDAQ:MYGN).

What does the smart money think about Myriad Genetics, Inc. (NASDAQ:MYGN)?

Heading into 2013, a total of 21 of the hedge funds we track held long positions in this stock, a change of 5% from one quarter earlier. With hedge funds’ sentiment swirling, there exists a few key hedge fund managers who were boosting their stakes substantially.

When looking at the hedgies we track, Chuck Royce’s Royce & Associates had the largest position in Myriad Genetics, Inc. (NASDAQ:MYGN), worth close to $260 million, accounting for 0.8% of its total 13F portfolio. The second largest stake is held by Jim Simons of Renaissance Technologies, with a $60 million position; the fund has 0.2% of its 13F portfolio invested in the stock. Some other hedge funds that hold long positions include D. E. Shaw’s D E Shaw, Ric Dillon’s Diamond Hill Capital and Donald Chiboucis’s Columbus Circle Investors.

As aggregate interest increased, specific money managers were breaking ground themselves. Columbus Circle Investors, managed by Donald Chiboucis, created the biggest position in Myriad Genetics, Inc. (NASDAQ:MYGN). Columbus Circle Investors had 18 million invested in the company at the end of the quarter. Jacob Gottlieb’s Visium Asset Management also made a $6 million investment in the stock during the quarter. The other funds with brand new MYGN positions are Glenn Russell Dubin’s Highbridge Capital Management, Mike Vranos’s Ellington, and Drew Cupps’s Cupps Capital Management.

Insider trading activity in Myriad Genetics, Inc. (NASDAQ:MYGN)

Insider buying is most useful when the primary stock in question has experienced transactions within the past six months. Over the last 180-day time frame, Myriad Genetics, Inc. (NASDAQ:MYGN) has seen zero unique insiders buying, and 8 insider sales (see the details of insider trades here).

With the results shown by Insider Monkey’s studies, retail investors must always keep an eye on hedge fund and insider trading sentiment, and Myriad Genetics, Inc. (NASDAQ:MYGN) is an important part of this process.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

The 13 Worst Looking Foods that Taste Great

The 6 Most Gruesome Injuries Suffered During a Sports Match

The 20 Biggest Contracts in MLB History

The 7 Worst Blown Calls in Sports History

7 Free Ways to Advertise Your Business Online

The 18 Best R&B Songs of the 90’s

The 10 Most Dangerous States to be a Cop

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!